Home » Cephalon Loses UK Bid to Halt Mylan Generic Sales
Cephalon Loses UK Bid to Halt Mylan Generic Sales
Cephalon Inc., maker of the sleep-disorder drug Provigil, can’t block Mylan Inc. and Orchid Chemicals & Pharmaceuticals Ltd. from selling generic versions of the drug in Britain before a patent trial, a judge ruled.
Bloomberg Businessweek
Bloomberg Businessweek
Upcoming Events
-
07May
-
14May
-
30May